UNIS/NAR/1471
11 May 2023
VIENNA, 11 May (UN Information Service) - The International Narcotics Control Board (INCB) has elected Professor Jallal Toufiq as its President at its 137th session.
INCB commenced its 137th session on 8 May with a meeting of its Standing Committee on Estimates, which reviewed national estimates of requirements for controlled substances for medical, scientific and industrial purposes.
On 10 May, the Board elected Professor Jallal Toufiq as its President and elected a new Bureau for a one-year term.
The composition of the Bureau is as follows:
Officers elected by the Board:
The outgoing president, Jagjit Pavadia, congratulated Professor Jallal Toufiq on his election and thanked the Board and secretariat for their support over the past two years. She also thanked Member States and other partners for their cooperation during her tenure.
* *** *
For further information, please contact:
INCB Secretariat
Telephone for media inquiries: (+43-1) 26060 4163
Email: incb.secretariat[at]un.org
Website: www.incb.org
With the deposit of the instrument of accession at the UN Headquarters in New York, Bahrain becomes the sixteenth State Party to the United Nations Convention on International Settlement Agreements Resulting from Mediation, also known as the "Singapore Convention on Mediation".
Visa-free entry, temporary protection and targeted anti-trafficking measures across Europe for refugees from Ukraine are effectively mitigating trafficking and smuggling risks, suggests a new study from the United Nations Office on Drugs and Crime (UNODC), launched today in Kyiv.
The new Permanent Representative of Ukraine to the United Nations (Vienna), Yurii Vitrenko, presented his credentials today to the Director-General of the United Nations Office at Vienna (UNOV), Ghada Waly.
During its 142nd session, the International Narcotics Control Board (INCB) focused on ensuring the functioning of the international drug control system and efforts to ensure the availability of controlled medicines and to prevent illicit drug manufacture, diversion and misuse.